KRYS
Krystal Biotech Inc
327.30$
+0.8%
vs. previous close
Closing price · As of: Oct 8, 2026
Statements
Cash Flow
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | – | -126.2% | – | -10.2% | -41.4% | +70.3% | -24.8% | +95.4% | +3.7% | -7.0% | – | |
| – | +10.4% | +6.8% | +25.6% | -24.3% | +1.7% | +5.1% | -5.6% | +4.3% | +9.5% | -13.6% | -10.9% | – | |
| – | +18.5% | -5.6% | +41.5% | +1.2% | +0.3% | +0.9% | +4.8% | -6.8% | +4.6% | -1.1% | +4.0% | – | |
| – | – | – | -628.4% | – | -131.1% | – | – | -5,743.1% | – | +47.5% | -79.2% | – | |
| – | +3.7% | -31.8% | -10.2% | -7.5% | -23.4% | +674.5% | -69.3% | -10.5% | +25.5% | +234.2% | -50.1% | – | |
| – | -109.7% | +155.7% | -25.5% | +77.4% | +144.1% | -34.6% | -80.8% | -59.3% | – | -669.6% | +154.1% | – | |
| – | – | – | – | – | – | – | – | – | – | – | -99.4% | – | |
| – | -80.4% | +304.1% | +0.5% | -68.4% | -27.8% | -613.4% | – | +106.5% | +322.4% | -166.8% | – | – | |
| – | -115.3% | – | -2,049.9% | – | -203.3% | – | – | -13.9% | +167.4% | -95.2% | -1,568.8% | – | |
| – | – | – | -136.2% | – | -10.0% | -52.4% | +105.2% | -25.3% | +98.6% | -2.8% | -2.7% | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: October 8, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.